Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Dr Mohammad Azam Ali

Dr Mohammad Azam Ali

Senior Lecturer & Director
University of Otago, Dunedin, New Zealand
New Zealand

Biography

Dr Azam Ali holds (BSc (hons.) & MSc) in Chemistry (Dhaka, Bangladesh) and PhD degree in Polymer & Materials Science and Engineering (USM) in the year 2000. He worked as a postdoctoral/research fellow in a numerous institutes e.g. POSTECH (South Korea) and University of North Carolina, Charlotte, UNCC (USA). Prior to his present position, he worked over 10 years in New Zealand Govt. research organisation (AgResearch) as a senior scientist, and leads biomaterials and medical devices research team at Lincoln, Christchurch, New Zealand. He is recognised as an international biomaterial scientist, have been working over 21 years in biomaterials areas, who has published more than 42 peer-reviewed articles and one book chapter. At present he holds 18 international patents and patent specifications. Dr. Azam is working as a senior lecturer and Director, Bioengineering program, and leads Biomaterials, Bioengineering and Regenerative Medicine research team in the Department of Applied Sciences, the University of Otago (Dunedin). He specialises in biomaterials (including biologic tissues), Bioengineering design, developing medical devices/technologies and nanoscience & nanotechnology. The innovative technology pioneered by Dr Azam uses low value protein sources from the New Zealand wool industry to create novel medical devices (e.g. wound care, bone implants, soft tissues, and bioabsorbable suture). Three of his chronic/diabetics wound care medical products have been commercialised and are manufactured in New Zealand for use as dressings (matrix), hydrogel, foam, particularly for chronic wounds management. They have already granted all regulatory (ISO 13485, FDA, TUV, TGA) approval and currently commercialised over 17 countries including in the USA, EU, AU & NZ. He was awarded the Bayer Year of the Innovators Awards 2010 (namely New Zealand Innovator Awards) or his significant science contribution to the Health and Science sectors.

Research Interest

Materials and Biomaterials (including biologic materials) Sciences, Engineering & Technology, Additive manufacturing (3D printing) & Electro(nano)spinning technology, Bioengineering and Medical devices/technology, Nanosciences and Technology: Functional and nanostructure biomaterials, Formulations (bioactives, drugs, etc.), microencapsulation and control released technology